Global /India /Healthcare /Drug Manufacturers - General /530313

Kimia Biosciences Ltd.

530313 (KIMIABL)

• BSE: 530313 • Delayed

35.85INR -0.9%

0.3795 USD

As of 26 June 2026, Kimia Biosciences Ltd. has a market cap of $17.96M USD, ranking #37771 globally and #2755 in India. It ranks #3373 in the Healthcare sector, and #1119 in the Drug Manufacturers - General industry.

Global Rank

37771

Country Rank

2755

Sector Rank

3373

Industry Rank

1119

Key Stats

Market Cap

$17.96MUSD

1.7B INR

Enterprise Value

$21.7MUSD

2.05B INR

Revenue (TTM)

$13.33MUSD

1.26B INR

EBITDA (TTM)

$2.05MUSD

193.44M INR

Net Income (TTM)

$958.25KUSD

90.52M INR

EBITDA Margin

15%

Profit Margin

7.2%

PE Ratio

18.8

PS Ratio

1.3

PB Ratio

14.6

EV/EBITDA

10.5

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Sameer Goel open_in_new

Employees

250

Founded

1993

Website

kimiabiosciences.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.9%	-2.2%	43%	20%	9.2%	6.6%	-6.1%	2.6%	-25%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	530313 (KIMIABL) Kimia Biosciences Ltd ISIN: INE285U01025 Shares Out.: Shares Outstanding: 47.313M¹ TV: TradingView: BSE: KIMIABL SA: Stock Analysis: BOM: 530313 YF: Yahoo Finance: 530313.BO GF: Google Finance: BOM: 530313 BA: Barron's: 530313 MS: Morningstar: XBOM: 530313	35.85 INR	TV: TradingView: BSE: KIMIABL SA: Stock Analysis: BOM: 530313 YF: Yahoo Finance: 530313.BO GF: Google Finance: BOM: 530313 BA: Barron's: 530313 MS: Morningstar: XBOM: 530313

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Kimia Biosciences Ltd.

Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India. The company offers and develops APIs in the categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, lipid lowering agents, vitamin, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals. It exports its products. Kimia Biosciences Limited was formerly known as Laurel Organics Ltd and changed its name to Kimia Biosciences Limited January 2019. The company was incorporated in 1993 and is based in New Delhi, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.18B 4.27T INR 252K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.36B 1.73T INR 102K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.16B 1.43T INR 84K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.72B 1.11T INR 65K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.86B 931.67B INR 55K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.7B 916.53B INR 54K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 4M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 3M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 2M%	97.4	United States
Roche Holding AG SIX: RO	$315.43B 256.25B CHF 2M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$283.76B 215.59B GBP 2M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 2M%	15.1	United States

chevron_leftBack